Jones Trading Initiates Coverage On Seaport Therapeutics with Buy Rating, Announces Price Target of $32

Benzinga Newsdesk www.benzinga.com Neutral 52.9%

Neg 0% Neu 52.9% Pos 0%

Jones Trading analyst Justin Walsh initiates coverage on Seaport Therapeutics (NASDAQ:SPTX) with a Buy rating and announces Price Target of $32.